Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LABSTANDARD BIOTOOLS INC.

Nasdaq · CIK 0001162194
Filer categoryAccelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts537

Identity from submissions API

NameSTANDARD BIOTOOLS INC.
CIK0001162194
TickersLAB
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC2834 Pharmaceutical Preparations
EIN770513190
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone6502666000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • FLUIDIGM CORP (2002-01-18T00:00:00.000Z → 2022-04-01T00:00:00.000Z)
Business address
50 MILK STREET
10TH FLOOR
BOSTON
MA
02109
MA
Mailing address
50 MILK STREET
10TH FLOOR
BOSTON
MA
02109
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1619 filing rows loaded from submissions recent; extra archives: CIK0001162194-submissions-001.json (614 filings, 2002-01-18 to 2016-08-02).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 425 425 0001140361-26-044935 001-34180 261575909 34 321240
2026-11-19 8-K 8-K 5.02,5.07,7.01,9.01 0001140361-26-044934 001-34180 261575860 34 517198 1 1
2026-11-16 425 425 0001140361-26-044225 001-34180 261561743 34 47260
2026-11-16 8-K 8-K 8.01 0001140361-26-044219 001-34180 261561625 34 190602 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001019056-26-000164 005-86635 261560106 34 12400
2026-11-05 4 4 0001193125-26-450238 4518
2026-11-03 10-Q 10-Q 0001193125-26-445534 001-34180 261518482 34 12456970 1 1
2026-11-03 425 425 0001140361-26-041711 001-34180 261514465 34 45252
2026-11-03 8-K 8-K 7.01,9.01 0001140361-26-041705 001-34180 261514449 34 190919 1 1
2026-10-30 424B3 424B3 0001140361-26-041305 333-297560 261507962 33 15456405
2026-10-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003310 333-297560 261477054 33 1828
2026-10-21 424B3 424B3 0001140361-26-040401 333-297560 261476062 33 15504851
2026-10-21 S-4/A S-4/A 0001140361-26-040313 333-297560 261474085 33 15938062
2026-10-09 S-4/A S-4/A 0001140361-26-039290 333-297560 261453741 33 14444906
2026-10-05 425 425 0001140361-26-038625 001-34180 261440591 34 46249
2026-10-05 8-K 8-K 7.01,9.01 0001140361-26-038624 001-34180 261440579 34 188739 1 1
2026-09-30 425 425 0001140361-26-038111 001-34180 261428165 34 885714
2026-09-30 8-K 8-K 1.01,1.02,7.01,9.01 0001140361-26-038110 001-34180 261428155 34 1211464 1 1
2026-09-09 S-4/A S-4/A 0001140361-26-036084 333-297560 261369001 33 14074432
2026-08-24 4 4 0001193125-26-363767 5177
2026-08-24 4 4 0001193125-26-363762 5162
2026-08-24 4 4 0001193125-26-363758 5147
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001385702-26-000005 005-86635 261282856 34 12090
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001019056-26-000130 005-86635 261275829 34 10532
2026-08-05 S-8 FORM S-8 0001104659-26-091220 333-298023 261244575 33 217997 1 1
2026-08-05 S-8 FORM S-8 0001104659-26-091219 333-298022 261244571 33 263135 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335103 001-34180 261243596 34 11933385 1 1
2026-08-05 8-K 8-K 2.02,7.01,9.01 0001193125-26-335106 001-34180 261243576 34 1132502 1 1
2026-08-04 4 4 0001193125-26-333225 5066
2026-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003074 005-86635 261221102 34 10844
2026-07-29 425 425 0001140361-26-029965 001-34180 261214055 34 659927
2026-07-29 8-K/A 8-K/A 9.01 0001140361-26-029964 001-34180 261214051 34 1065522 1 1
2026-07-28 425 425 0001140361-26-029844 001-34180 261207633 34 1830773
2026-07-28 425 425 0001140361-26-029842 001-34180 261207593 34 88573
2026-07-28 8-K 8-K 1.01,7.01,9.01 0001140361-26-029841 001-34180 261207585 34 263092 1 1
2026-07-27 4 4 0001193125-26-318442 5299
2026-07-24 8-K 8-K 3.01 0001193125-26-316183 001-34180 261201960 34 193846 1 1
2026-07-20 425 425 0001140361-26-028877 001-34180 261185185 34 23027
2026-07-20 S-4 S-4 0001140361-26-028868 333-297560 261185124 33 12166513 1 1
2026-06-23 4 4 0001193125-26-279834 7306
2026-06-23 4 4 0001193125-26-279833 5120
2026-06-23 4 4 0001193125-26-279830 8297
2026-06-23 4 4 0001193125-26-279828 11000
2026-06-23 4 4 0001193125-26-279827 7447
2026-06-23 4 4 0001193125-26-279824 7359
2026-06-23 4 4 0001193125-26-279823 7362
2026-06-18 8-K 8-K 5.02,5.07,9.01 0001193125-26-275946 001-34180 261103191 34 647200 1 1
2026-06-12 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000905148-26-002940 005-86635 261088153 34 39242
2026-06-09 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000919574-26-003923 005-86635 261077297 34 40793
2026-06-08 425 425 0001104659-26-071198 001-34180 261071125 34 9110062
2026-06-08 8-K FORM 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001104659-26-071195 001-34180 261071116 34 9602565 1 1
2026-06-05 8-K 8-K 8.01 0001193125-26-259877 001-34180 261070099 34 134967 1 1
2026-06-03 8-K 8-K 5.02 0001193125-26-255403 001-34180 261060577 34 192984 1 1
2026-05-29 SD SD 0001193125-26-248229 001-34180 261044241 34 829962
2026-05-28 8-K 8-K 5.02,9.01 0001193125-26-245181 001-34180 261035549 34 768535 1 1
2026-05-22 4 4 0001193125-26-237189 5192
2026-05-22 4 4 0001193125-26-237182 5202
2026-05-22 4 4 0001193125-26-237181 5177
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001426156-26-000013 005-86635 26990170 34 12143
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-002428 005-86635 26990054 34 36796
2026-05-06 10-Q 10-Q 0001193125-26-208967 001-34180 26948461 34 10048666 1 1
2026-05-05 8-K 8-K 2.02,7.01,9.01 0001193125-26-206395 001-34180 26943161 34 865275 1 1
2026-04-27 ARS ARS 0001140361-26-017115 001-34180 26901323 34 2089345
2026-04-27 DEFA14A DEFA14A 0001140361-26-017107 001-34180 26901286 34 3723344
2026-04-27 DEF 14A DEF 14A 0001140361-26-017100 001-34180 26901264 34 8406528 1 1
2026-04-24 8-K 8-K 3.01 0001193125-26-177290 001-34180 26894164 34 181058 1 1
2026-04-08 4 4 0001193125-26-148615 12922
2026-04-08 4 4 0001193125-26-148614 7509
2026-04-08 4 4 0001193125-26-148613 12929
2026-03-16 10-K 10-K 0001193125-26-108326 001-34180 26756664 34 36141035 1 1
2026-03-02 4 4 0001193125-26-086197 8664
2026-03-02 4 4 0001193125-26-086158 5111
2026-03-02 4 4 0001193125-26-086154 4978
2026-02-24 4 4 0001193125-26-067641 5008
2026-02-24 4 4 0001193125-26-067638 5029
2026-02-24 4 4 0001193125-26-067636 5243
2026-02-24 8-K 8-K 2.02,7.01,9.01 0001193125-26-067026 001-34180 26671785 34 1189017 1 1
2026-02-05 8-K/A FORM 8-K/A 9.01 0001104659-26-010965 001-34180 26603577 34 381215 1 1
2026-01-30 8-K FORM 8-K 2.01,2.02,7.01,9.01 0001104659-26-008375 001-34180 26580781 34 256594 1 1
2026-01-08 8-K 8-K 2.02,9.01 0001193125-26-006996 001-34180 26517348 34 294573 1 1
2026-01-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001019056-26-000002 005-86635 26516747 34 19562
2025-12-04 4 xslF345X05/ownership.xml 0000919574-25-007243 26588
2025-11-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000919574-25-007210 005-86635 251536581 34 58846
2025-11-26 4 xslF345X05/ownership.xml 0000919574-25-007187 24392
2025-11-24 4 4 0001193125-25-293843 5043
2025-11-24 4 4 0001193125-25-293842 5058
2025-11-24 4 4 0001193125-25-293841 5063
2025-11-20 4 xslF345X05/ownership.xml 0000919574-25-007124 26590
2025-11-17 4 xslF345X05/ownership.xml 0000919574-25-007087 26588
2025-11-12 4 xslF345X05/ownership.xml 0000919574-25-006597 28779
2025-11-04 10-Q 10-Q 0001193125-25-264695 001-34180 251449126 34 12529359 1 1
2025-11-04 8-K 8-K 2.02,7.01,9.01 0001193125-25-264693 001-34180 251449115 34 2168959 1 1
2025-09-17 8-K 8-K 2.05 0001193125-25-206150 001-34180 251320044 34 194240 1 1
2025-09-11 4 xslF345X05/ownership.xml 0000919574-25-005636 22186
2025-09-05 4 xslF345X05/ownership.xml 0000919574-25-005603 24401
2025-09-03 8-K 8-K 2.05 0000950170-25-112662 001-34180 251287672 34 194439 1 1
2025-08-26 4 xslF345X05/ownership.xml 0000919574-25-005152 25562
2025-08-22 4 4 0000950170-25-111052 5010
2025-08-22 4 4 0001193125-25-186506 5063
2025-08-22 4 4 0000950170-25-111050 5056
2025-08-15 4 xslF345X05/ownership.xml 0000919574-25-004979 25908
2025-08-15 S-8 FORM S-8 0001104659-25-079241 333-289643 251224757 33 201412 1 1
2025-08-15 10-Q 10-Q 0000950170-25-109388 001-34180 251224623 34 12090129 1 1
2025-08-12 NT 10-Q NT 10-Q 0000950170-25-106827 001-34180 251203606 34 57483
2025-08-11 8-K 8-K 2.02,7.01,9.01 0000950170-25-106636 001-34180 251202805 34 2162366 1 1
2025-08-05 4 4 0000950170-25-103300 5245
2025-08-05 4 4 0000950170-25-103296 5197
2025-08-01 8-K 8-K 5.02 0000950170-25-101439 001-34180 251176476 34 190869 1 1
2025-07-30 4/A 4/A 0000950170-25-100490 4204
2025-06-24 4 4 0000950170-25-089657 7342
2025-06-24 4 4 0000950170-25-089654 7238
2025-06-24 4 4 0000950170-25-089653 7201
2025-06-24 4 4 0000950170-25-089651 10928
2025-06-24 4 4 0000950170-25-089644 7242
2025-06-24 4 4 0000950170-25-089641 8192
2025-06-23 8-K FORM 8-K 1.01,7.01,9.01 0001104659-25-061438 001-34180 251063136 34 1024382 1 1
2025-06-20 8-K 8-K 5.02,5.07,9.01 0000950170-25-088519 001-34180 251061565 34 430607 1 1
2025-06-02 SD SD 0000950170-25-080245 001-34180 251014970 34 536928
2025-05-30 4 4 0000950170-25-079890 4952
2025-05-30 4 4 0000950170-25-079886 4957
2025-05-30 4 4 0000950170-25-079885 5002
2025-05-28 4 4 0000950170-25-078466 5350
2025-05-28 4 4 0000950170-25-078463 5300
2025-05-28 4 4 0000950170-25-078457 5317
2025-05-27 4 4 0000950170-25-078048 5350
2025-05-27 4 4 0000950170-25-078043 5317
2025-05-23 4 4 0000950170-25-077191 7081
2025-05-23 144 xsl144X01/primary_doc.xml 0001959173-25-003482 001-34180 25982559 33 5846
2025-05-23 144 xsl144X01/primary_doc.xml 0001959173-25-003481 001-34180 25982547 33 5899
2025-05-23 144 xsl144X01/primary_doc.xml 0001959173-25-003475 001-34180 25982256 33 5924
2025-05-22 4 4 0000950170-25-076591 7043
2025-05-22 4 4 0000950170-25-076590 7074
2025-05-22 144 xsl144X01/primary_doc.xml 0001959173-25-003444 001-34180 25977423 33 5290
2025-05-22 144 xsl144X01/primary_doc.xml 0001959173-25-003441 001-34180 25977264 33 5216
2025-05-22 144 xsl144X01/primary_doc.xml 0001959173-25-003438 001-34180 25977129 33 5263
2025-05-21 144 xsl144X01/primary_doc.xml 0001959173-25-003407 001-34180 25973442 33 4629
2025-05-21 144 xsl144X01/primary_doc.xml 0001959173-25-003406 001-34180 25973365 33 4577
2025-05-21 144 xsl144X01/primary_doc.xml 0001959173-25-003405 001-34180 25973277 33 4659
2025-05-06 10-Q 10-Q 0000950170-25-064606 001-34180 25918198 34 10340646 1 1
2025-05-06 8-K 8-K 2.02,7.01,9.01 0000950170-25-064439 001-34180 25917191 34 1071669 1 1
2025-04-30 ARS ARS 0001140361-25-016517 001-34180 25890986 34 2474201
2025-04-30 DEFA14A DEFA14A 0001140361-25-016516 001-34180 25890985 34 865894
2025-04-30 DEF 14A DEF 14A 0001140361-25-016515 001-34180 25890981 34 7367188 1 1
2025-04-08 4 4 0000950170-25-052047 8699
2025-04-08 4 4 0000950170-25-052046 8701
2025-03-24 4 4 0000950170-25-044012 7660
2025-03-24 4 4 0000950170-25-044011 7356
2025-03-24 4 4 0000950170-25-044008 7366
2025-03-11 10-K 10-K 0000950170-25-036608 001-34180 25725246 34 39146036 1 1
2025-03-04 4 xslF345X05/ownership.xml 0000919574-25-001777 28732
2025-03-04 4/A xslF345X05/ownership.xml 0000919574-25-001776 20037
2025-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000919574-25-001773 005-86635 25707906 34 44637
2025-03-04 4 4 0000950170-25-032559 5019
2025-03-04 4 4 0000950170-25-032552 5151
2025-02-26 8-K 8-K 2.02,7.01,9.01 0000950170-25-027712 001-34180 25669931 34 1720964 1 1
2025-02-24 4 4 0000950170-25-025806 5180
2025-01-13 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-002848 001-34180 25524775 34 5863249 1 1
2025-01-10 8-K 8-K 5.02 0000950170-25-004155 001-34180 25522947 34 187306 1 1
2024-12-20 8-K 8-K 9.01 0000950170-24-139051 001-34180 241568116 34 4374866 1 1
2024-11-21 4 4 0000950170-24-129877 4966
2024-11-14 SC 13G/A form_sc13ga-standard.htm 0001011438-24-000664 005-86635 241461040 34 89173
2024-11-12 SC 13G/A UnitedStates_13G__StandardBi.txt 0000932471-24-001307 005-86635 241450365 34 6696
2024-11-12 144 xsl144X01/primary_doc.xml 0001959173-24-007763 001-34180 241448287 33 6689
2024-11-08 SC 13G us34385p1084_110824.txt 0002012383-24-003417 005-86635 241439560 34 13996
2024-11-07 8-K 8-K 5.02,9.01 0000950170-24-122823 001-34180 241433295 34 210198 1 1
2024-11-06 10-Q 10-Q 0000950170-24-122473 001-34180 241432229 34 14068041 1 1
2024-11-04 SC 13G/A UnitedStates_13G__StandardBi.txt 0000932471-24-000739 005-86635 241422513 34 5741
2024-10-30 8-K 8-K 2.02,7.01,9.01 0000950170-24-119014 001-34180 241410588 34 1214135 1 1
2024-10-24 SC 13G us34385p1084_102424.txt 0002012383-24-002218 005-86635 241392079 34 13982
2024-10-21 SC 13G/A LAB_SC13GA1.htm 0001273087-24-000105 005-86635 241383776 34 81827
2024-09-09 144 xsl144X01/primary_doc.xml 0001959173-24-006339 001-34180 241287060 33 4617
2024-09-05 4 4 0000950170-24-104133 5023
2024-09-05 4 4 0000950170-24-104132 4966
2024-09-05 8-K FORM 8-K 7.01,9.01 0001104659-24-097368 001-34180 241281451 34 5728922 1 1
2024-09-03 3 3 0000950170-24-102981 17128
2024-08-30 8-K FORM 8-K 5.02,9.01 0001104659-24-095596 001-34180 241269971 34 354317 1 1
2024-08-29 4 xslF345X05/ownership.xml 0000919574-24-005134 25684
2024-08-26 4 xslF345X05/ownership.xml 0000919574-24-004878 30134
2024-08-21 4 xslF345X05/ownership.xml 0000919574-24-004812 29882
2024-08-19 4 4 0000950170-24-098700 8849
2024-08-16 4 xslF345X05/ownership.xml 0000919574-24-004802 26443
2024-08-14 SC 13D/A d11444578_13d-a.htm 0000919574-24-004765 005-86635 241210342 34 177739
2024-08-13 4 xslF345X05/ownership.xml 0000919574-24-004593 30823
2024-08-09 4 xslF345X05/ownership.xml 0000919574-24-004339 27925
2024-08-06 4 xslF345X05/ownership.xml 0000919574-24-004280 29534
2024-08-06 S-8 FORM S-8 0001104659-24-086311 333-281295 241179993 33 86773
2024-08-06 10-Q 10-Q 0000950170-24-091888 001-34180 241179832 34 14456321 1 1
2024-07-31 8-K FORM 8-K 5.02,9.01 0001104659-24-084362 001-34180 241162281 34 212568 1 1
2024-07-31 8-K 8-K 2.02,7.01,9.01 0000950170-24-088578 001-34180 241162073 34 1230626 1 1
2024-07-23 4 4 0000950170-24-085790 10773
2024-07-02 4 4 0000950170-24-080785 8201
2024-07-02 4 4 0000950170-24-080745 7741
2024-07-02 4 4 0000950170-24-080723 13206
2024-07-02 4 4 0000950170-24-080719 7248
2024-07-02 4 4 0000950170-24-080717 7604
2024-07-02 4 4 0000950170-24-080702 7640
2024-07-01 8-K FORM 8-K 5.02,5.07,9.01 0001104659-24-076823 001-34180 241090502 34 361141 1 1
2024-06-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-27 16:00:00 9999999995-24-002002 333-280321 241081163 33 1888
2024-06-26 3 xslF345X02/ownership.xml 0000919574-24-003822 5303
2024-06-25 CORRESP filename1.htm 0001104659-24-074820 8339
2024-06-25 UPLOAD filename1.pdf 0000000000-24-007160 333-280321 40537
2024-06-24 144 xsl144X01/primary_doc.xml 0001959173-24-004611 001-34180 241065370 33 5219
2024-06-24 144 xsl144X01/primary_doc.xml 0001959173-24-004607 001-34180 241064890 33 5227
2024-06-24 144 xsl144X01/primary_doc.xml 0001959173-24-004602 001-34180 241064427 33 5228
2024-06-21 4 xslF345X05/ownership.xml 0000919574-24-003795 28927
2024-06-20 S-3 S-3 0001104659-24-072927 333-280321 241053271 33 1245126
2024-06-03 SC 13D/A d11065386_13d-a.htm 0000919574-24-003487 005-86635 241014989 34 188490
2024-06-03 DEFA14A DEFA14A 0001140361-24-028636 001-34180 241014972 34 1658045
2024-06-03 8-K FORM 8-K 8.01 0001104659-24-067384 001-34180 241011889 34 196354 1 1
2024-05-29 SD e663651_sd-sb.htm 0001193805-24-000721 001-34180 24999004 34 174454
2024-05-28 4 xslF345X05/ownership.xml 0000919574-24-003356 25606
2024-05-22 4 xslF345X05/ownership.xml 0000919574-24-003308 30469
2024-05-22 SC 13D/A d11057183_13d-a.htm 0000919574-24-003302 005-86635 24974129 34 172028
2024-05-21 4 4 0000950170-24-063097 7394
2024-05-21 4 4 0000950170-24-063094 7392
2024-05-21 4 4 0000950170-24-063091 7435
2024-05-21 ARS ARS 0001140361-24-027070 001-34180 24970668 34 1122643
2024-05-21 DEFC14A ny20016518x3_defc14a.htm 0001140361-24-027068 001-34180 24970651 34 4354126
2024-05-20 PRER14A PRER14A 0001140361-24-026755 001-34180 24962252 34 5153224
2024-05-17 4 xslF345X05/ownership.xml 0000919574-24-003252 30508
2024-05-17 UPLOAD filename1.pdf 0000000000-24-005791 001-34180 46090
2024-05-16 4 4 0000950170-24-061315 8749
2024-05-10 PREC14A ny20016518x1_prec14a.htm 0001140361-24-025499 001-34180 24936017 34 4382729
2024-05-09 10-Q 10-Q 0000950170-24-057213 001-34180 24931585 34 12836417 1 1
2024-05-08 8-K 8-K 2.01,7.01,9.01 0000950170-24-055791 001-34180 24926739 34 877433 1 1
2024-04-26 10-K/A FORM 10-K/A 0001104659-24-053067 001-34180 24884970 34 1050910 1 1
2024-04-25 8-K FORM 8-K 2.05,7.01,9.01 0001104659-24-051640 001-34180 24873087 34 227909 1 1
2024-04-09 4 4 0000950170-24-043103 5134
2024-04-05 4 4 0000950170-24-042373 10855
2024-04-05 4 4 0000950170-24-042372 8977
2024-04-04 144 xsl144X01/primary_doc.xml 0001959173-24-002836 001-34180 24822933 33 4590
2024-04-04 144 xsl144X01/primary_doc.xml 0001959173-24-002833 001-34180 24822904 33 5225
2024-03-20 SC 13G/A sayw24032001_13ga.htm 0000905148-24-000993 005-86635 24768861 34 398491
2024-03-20 3 xslF345X02/form3.xml 0000905148-24-000992 17787
2024-03-20 4 xslF345X05/ownership.xml 0000919574-24-002115 31467
2024-03-20 SC 13D/A d11007253_13d-a.htm 0000919574-24-002111 005-86635 24768669 34 182169
2024-03-19 144 xsl144X01/primary_doc.xml 0001959173-24-002500 001-34180 24764157 33 5090
2024-03-18 144 xsl144X01/primary_doc.xml 0001959173-24-002457 001-34180 24759820 33 4454
2024-03-18 8-K FORM 8-K 1.01,3.02,5.02,5.03,7.01,9.01 0001104659-24-035297 001-34180 24757078 34 377124 1 1
2024-03-14 144 xsl144X01/primary_doc.xml 0001959173-24-002348 001-34180 24749392 33 4435
2024-03-06 4 xslF345X05/ownership.xml 0000919574-24-001888 26485
2024-03-01 10-K 10-K 0000950170-24-023845 001-34180 24709733 34 15790607 1 1
2024-02-28 8-K 8-K 2.02,7.01,9.01 0000950170-24-022060 001-34180 24695221 34 916960 1 1
2024-02-26 SC 13G LAB_SC13G.htm 0001273087-24-000051 005-86635 24678907 34 81926
2024-02-22 4 4 0000950170-24-018893 10321
2024-02-14 SC 13G/A form_sc13ga-standard.htm 0001011438-24-000258 005-86635 24636857 34 88140
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-022000 005-86635 24629585 34 13153
2024-02-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-07 16:00:00 9999999995-24-000347 333-276628 24606682 33 1887
2024-02-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-07 16:00:00 9999999995-24-000346 333-276626 24606681 33 1887
2024-02-05 CORRESP filename1.htm 0001104659-24-010625 9261
2024-02-05 CORRESP filename1.htm 0001104659-24-010622 9862
2024-02-02 S-3/A S-3/A 0001104659-24-010096 333-276628 24592340 33 98166
2024-02-01 UPLOAD filename1.pdf 0000000000-24-001289 333-276628 40541
2024-02-01 UPLOAD filename1.pdf 0000000000-24-001287 333-276626 40541
2024-01-19 S-3 FORM S-3 0001104659-24-005274 333-276628 24546384 33 404206
2024-01-19 S-3 S-3 0001104659-24-005272 333-276626 24546372 33 516251
2024-01-19 S-8 FORM S-8 0001104659-24-005270 333-276625 24546358 33 252359
2024-01-19 S-8 FORM S-8 0001104659-24-005257 333-276620 24546209 33 96906
2024-01-19 8-K/A FORM 8-K/A 9.01 0001104659-24-005246 001-34180 24546054 34 1965042 1 1
2024-01-12 SC 13D/A formsc13da-01122024_070144.htm 0001415889-24-001017 005-86635 24531620 34 268216
2024-01-09 4 xslF345X05/ownership.xml 0000919574-24-000224 23073
2024-01-09 4 OWNERSHIP DOCUMENT 0001104659-24-002655 29928
2024-01-09 4 OWNERSHIP DOCUMENT 0001104659-24-002654 23292
2024-01-09 4 OWNERSHIP DOCUMENT 0001104659-24-002652 8904
2024-01-09 4 OWNERSHIP DOCUMENT 0001104659-24-002651 8946
2024-01-09 3 OWNERSHIP DOCUMENT 0001104659-24-002650 11508
2024-01-09 3 OWNERSHIP DOCUMENT 0001104659-24-002649 11379
2024-01-09 3 OWNERSHIP DOCUMENT 0001104659-24-002648 11874
2024-01-09 SC 13D/A d10932246_13d-a.htm 0000919574-24-000217 005-86635 24524104 34 181299
2024-01-09 SC 13G SC 13G 0001140361-24-001535 005-86635 24523815 34 407605
2024-01-08 SC 13D/A STANDARD BIOTOOLS, INC. 0000902664-24-000080 005-86635 24520902 34 51159
2024-01-08 8-K FORM 8-K 2.02,7.01,9.01 0001104659-24-002092 001-34180 24518546 34 7116156 1 1
2024-01-05 8-K FORM 8-K 2.01,5.02,5.03,5.07,8.01,9.01 0001104659-24-001640 001-34180 24514541 34 465487 1 1
2023-12-29 425 425 0001104659-23-130529 53433
2023-12-29 8-K FORM 8-K 8.01,9.01 0001104659-23-130528 001-34180 231528684 34 243563 1 1
2023-12-26 425 425 0001104659-23-128930 53687
2023-12-26 8-K FORM 8-K 8.01,9.01 0001104659-23-128923 001-34180 231511126 34 243913 1 1
2023-12-22 424B3 424B3 0001104659-23-128362 333-275533 231506725 33 298106
2023-12-19 425 425 0001104659-23-127358 25921968
2023-12-19 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-127352 001-34180 231497996 34 26121924 1 1
2023-12-04 425 425 0001104659-23-123268 54838
2023-12-04 8-K FORM 8-K 8.01,9.01 0001104659-23-123266 001-34180 231464074 34 245350 1 1
2023-12-01 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-12-01 16:00:00 9999999995-23-003518 333-275533 231461183 33 1816
2023-12-01 424B3 424B3 0001104659-23-122872 333-275533 231460024 33 4913608
2023-12-01 CORRESP filename1.htm 0001104659-23-122728 9045
2023-12-01 S-4/A S-4/A 0001104659-23-122524 333-275533 231457335 33 5903042
2023-11-29 425 425 0001104659-23-121726 5593050
2023-11-29 8-K FORM 8-K 7.01,9.01 0001104659-23-121725 001-34180 231448207 34 5791293 1 1
2023-11-27 UPLOAD filename1.pdf 0000000000-23-012893 40539
2023-11-22 SC 13D/A SC 13D/A 0001140361-23-054447 005-86635 231433672 34 333745
2023-11-21 425 425 0001104659-23-120368 001-34180 231428314 34 33637
2023-11-21 8-K FORM 8-K 8.01 0001104659-23-120363 001-34180 231428297 34 216048 1 1
2023-11-14 S-4 S-4 0001104659-23-117457 333-275533 231401204 33 5105436
2023-11-13 CORRESP filename1.htm 0001104659-23-117458 9815
2023-11-08 425 425 0001104659-23-115384 20895
2023-11-07 10-Q 10-Q 0000950170-23-060385 001-34180 231384968 34 13104460 1 1
2023-11-07 8-K 8-K 2.02,7.01,9.01 0000950170-23-060237 001-34180 231383724 34 1113913 1 1
2023-10-20 4 4 0000950170-23-054492 5499
2023-10-16 SC 13D SC 13D 0001140361-23-048351 005-86635 231327629 34 368385
2023-10-04 425 425 0001104659-23-106842 001-34180 231308403 34 63501
2023-10-04 425 425 0001104659-23-106840 001-34180 231308386 34 37039
2023-10-04 425 425 0001104659-23-106839 001-34180 231308376 34 18367
2023-10-04 425 425 0001104659-23-106838 001-34180 231308369 34 23025
2023-10-04 425 425 0001104659-23-106836 001-34180 231308360 34 18786
2023-10-04 425 425 0001104659-23-106610 001-34180 231306612 34 6602709
2023-10-04 8-K FORM 8-K 1.01,7.01,8.01,9.01 0001104659-23-106606 001-34180 231306600 34 7085937 1 1
2023-08-23 144 xsl144X01/primary_doc.xml 0001959173-23-003467 001-34180 231196624 33 5023
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003339 001-34180 231181463 33 5459
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003177 001-34180 231165368 33 13007
2023-08-08 10-Q 10-Q 0001628280-23-028287 001-34180 231152615 34 7991630 1 1
2023-08-08 8-K 8-K 2.02,7.01,9.01 0001162194-23-000055 001-34180 231151838 34 459515 1 1
2023-07-28 8-K 8-K 5.02 0001162194-23-000053 001-34180 231123978 34 410766 1 1
2023-07-07 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-23-002569 005-86635 231076187 34 27503
2023-07-03 4 xslF345X04/ownership.xml 0000902664-23-003816 9221
2023-07-03 SC 13D/A STANDARD BIOTOOLS, INC. 0000902664-23-003815 005-86635 231065972 34 47233
2023-06-20 S-8 S-8 0001162194-23-000037 333-272753 231022839 33 124665
2023-06-16 4 FORM 4 0001162194-23-000050 321408
2023-06-16 4 FORM 4 0001162194-23-000048 321392
2023-06-16 4 FORM 4 0001162194-23-000046 321544
2023-06-16 4 FORM 4 0001162194-23-000044 320450
2023-06-16 4 FORM 4 0001162194-23-000041 321037
2023-06-16 4 FORM 4 0001162194-23-000039 320808
2023-06-16 8-K 8-K 5.02,5.07,9.01 0001162194-23-000033 001-34180 231022291 34 390032 1 1
2023-05-26 SD sd00322lab_05262023.htm 0000921895-23-001371 001-34180 23969019 34 204089
2023-05-22 4 FORM 4 0001162194-23-000030 6866
2023-05-19 4 xslF345X04/ownership.xml 0000919574-23-003426 10545
2023-05-19 4 xslF345X04/ownership.xml 0000919574-23-003425 20063
2023-05-19 3 xslF345X02/ownership.xml 0000919574-23-003424 3882
2023-05-17 4 FORM 4 0001162194-23-000028 7983
2023-05-17 3 FORM 3 0001162194-23-000026 5354
2023-05-15 8-K FORM 8-K 5.02,9.01 0000950142-23-001458 001-34180 23924288 34 433977 1 1
2023-05-09 10-Q 10-Q 0001162194-23-000024 001-34180 23903352 34 14651478 1 1
2023-05-09 8-K FORM 8-K 2.02,9.01 0000950142-23-001396 001-34180 23902796 34 354879 1 1
2023-05-03 8-K FORM 8-K 5.02 0000950142-23-001328 001-34180 23884204 34 198068 1 1
2023-04-28 DEFA14A DEFA14A 0000950142-23-001248 001-34180 23867078 34 448368
2023-04-28 DEF 14A DEF 14A 0000950142-23-001246 001-34180 23867030 34 1022531
2023-04-06 4 FORM 4 0001162194-23-000021 6891
2023-04-06 4 FORM 4 0001162194-23-000019 7159
2023-03-17 4 FORM 4 0001162194-23-000017 4721
2023-03-17 3 FORM 3 0001162194-23-000015 3160
2023-03-16 8-K FORM 8-K 5.02,9.01 0000950142-23-000726 001-34180 23738857 34 227588 1 1
2023-03-14 10-K 10-K 0001162194-23-000013 001-34180 23731772 34 19302470 1 1
2023-03-13 8-K FORM 8-K 8.01 0000950142-23-000674 001-34180 23725547 34 198264 1 1
2023-02-23 4 FORM 4 0001162194-23-000010 8322
2023-02-23 4 FORM 4 0001162194-23-000008 23595
2023-02-22 4 FORM 4 0001162194-23-000006 4501
2023-02-14 SC 13G/A AMENDMENT NO. 1 0000950142-23-000412 005-86635 23630322 34 66815
2023-02-14 8-K FORM 8-K 2.02,9.01 0000950142-23-000411 001-34180 23629410 34 370832 1 1
2023-02-14 SC 13G/A SC 13G/A 0001140361-23-006811 005-86635 23626279 34 410540
2023-02-14 SC 13G/A form_sc13ga-standard.htm 0001011438-23-000276 005-86635 23624074 34 106399
2023-02-09 SC 13G PRIMECAP MANAGEMENT CO/CA/ 0001085146-23-000909 005-86635 23606125 34 27447
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-017009 005-86635 23604310 34 13078
2023-01-20 4 FORM 4 0001162194-23-000004 5515
2023-01-20 4 FORM 4 0001162194-23-000002 5532
2023-01-09 8-K FORM 8-K 2.02,9.01 0000950142-23-000074 001-34180 23516766 34 4339180 1 1
2022-12-30 4 xslF345X03/ownership.xml 0000902664-22-005341 5826
2022-12-30 SC 13D/A STANDARD BIOTOOLS INC. 0000902664-22-005340 005-86635 221502560 34 47254
2022-11-28 8-K FORM 8-K 8.01,9.01 0000950142-22-003269 001-34180 221425920 34 245671 1 1
2022-11-22 4 FORM 4 0001162194-22-000101 16444
2022-11-14 SC 13G/A SC 13G/A 0001104659-22-118664 005-86635 221386802 34 79283
2022-11-09 10-Q 10-Q 0001162194-22-000098 001-34180 221372754 34 11282620 1 1
2022-11-08 8-K FORM 8-K 2.02,9.01 0001171843-22-007235 001-34180 221369087 34 461121 1 1
2022-08-24 4 FORM 4 0001162194-22-000093 16493
2022-08-09 10-Q 10-Q 0001162194-22-000091 001-34180 221148762 34 9702438 1 1
2022-08-08 8-K FORM 8-K 2.02,2.05,9.01 0001171843-22-005465 001-34180 221144735 34 465577 1 1
2022-08-05 SC 13D/A p22-1967sc13da.htm 0000902664-22-003824 005-86635 221139244 34 52931
2022-08-05 4 xslF345X03/ownership.xml 0000902664-22-003823 9480
2022-08-03 8-K 8-K 5.02 0001162194-22-000088 001-34180 221133633 34 177026 1 1
2022-08-02 4 xslF345X03/ownership.xml 0000902664-22-003778 11382
2022-07-08 SC 13G us34385p1084_070822.txt 0000834237-22-010287 005-86635 221075040 34 12270
2022-07-07 8-K 8-K 5.02 0001162194-22-000086 001-34180 221071664 34 176636 1 1
2022-06-27 8-K 8-K 5.02 0001162194-22-000084 001-34180 221044531 34 179445 1 1
2022-06-17 4 FORM 4 0001162194-22-000082 6995
2022-06-17 4 FORM 4 0001162194-22-000080 6996
2022-06-17 4 FORM 4 0001162194-22-000079 6946
2022-06-17 4 FORM 4 0001162194-22-000078 6964
2022-06-17 4 FORM 4 0001162194-22-000077 6991
2022-06-17 4 FORM 4 0001162194-22-000076 6967
2022-06-17 4 FORM 4 0001162194-22-000075 7316
2022-06-16 8-K 8-K 5.07 0001162194-22-000067 001-34180 221020152 34 198941 1 1
2022-06-15 4 xslF345X03/ownership.xml 0000902664-22-003296 7579
2022-06-07 SC 13D/A STANDARD BIOTOOLS, INC. 0000902664-22-003184 005-86635 221000203 34 51060
2022-06-06 4 xslF345X03/ownership.xml 0000902664-22-003177 9491
2022-06-03 4 FORM 4 0001162194-22-000065 4951
2022-05-31 SD SD 0001162194-22-000063 001-34180 22979790 34 370260
2022-05-27 424B3 424B3 0001193125-22-162097 333-265010 22975618 33 239923
2022-05-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-26 16:00:00 9999999995-22-001605 333-265010 22972441 33 1815
2022-05-25 CORRESP filename1.htm 0001193125-22-159802 7257
2022-05-24 UPLOAD filename1.pdf 0000000000-22-005724 40280
2022-05-23 4 FORM 4 0001162194-22-000061 22898
2022-05-23 4 FORM 4 0001162194-22-000060 15610
2022-05-23 4 FORM 4 0001162194-22-000059 23727
2022-05-17 S-3 S-3 0001193125-22-152983 333-265010 22934402 33 370711
2022-05-10 4 xslF345X03/ownership.xml 0000902664-22-002849 9008
2022-05-09 10-Q 10-Q 0001162194-22-000055 001-34180 22904398 34 9030453 1 1
2022-05-05 8-K FORM 8-K 2.02,9.01 0001171843-22-003333 001-34180 22896338 34 381407 1 1
2022-05-03 SC 13D/A STANDARD BIOTOOLS, INC. 0000902664-22-002749 005-86635 22885558 34 52741
2022-05-02 4 xslF345X03/ownership.xml 0000902664-22-002740 11398
2022-04-29 DEFA14A DEFA14A 0001162194-22-000051 001-34180 22877824 34 1147301
2022-04-29 DEF 14A DEF 14A 0001162194-22-000050 001-34180 22877701 34 3279827

Latest XBRL company facts

One latest value per concept from companyfacts (537 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 394.79M 2026-11-01 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
dei EntityPublicFloat Entity Public Float USD 290.90M 2025-06-30 2025 FY 10-K 2026-03-16 0001193125-26-108326
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 186.58M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017100
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.92M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017100
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.85M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017100
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017100
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 21.33 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017100
ffd NetFeeAmt NetFeeAmt USD 7,212.28 2026-08-04 S-8 2026-08-05 0001104659-26-091219
ffd TtlFeeAmt TtlFeeAmt USD 7,212.28 2026-08-04 S-8 2026-08-05 0001104659-26-091219
ffd TtlOfferingAmt TtlOfferingAmt USD 52.23M 2026-08-04 S-8 2026-08-05 0001104659-26-091219
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-8 2026-08-05 0001104659-26-091219
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-20 S-4 2026-07-20 0001140361-26-028868
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 1.48M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 12.98M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 595,000 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 4.26M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.23M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 30.44M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 2.30M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 994,000 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 13.95M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 1.01M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 2.71M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 52.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 354,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.75B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD 557,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001162194-21-000013
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 4.04M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.72M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 176,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap AdvertisingExpense Advertising Expense USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AllowanceForDoubtfulAccountsReceivableChargeOffs Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) USD 15,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 312,000 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 40,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 770,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 48.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060385
us-gaap Assets Assets USD 635.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AssetsCurrent Assets, Current USD 497.30M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 70.77M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001162194-16-000224
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3.54M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 544.66M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 40.42M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 47.05M 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311107
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 20.10M 2012-09-30 2012 Q3 10-Q 2012-11-09 0001193125-12-463140
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 52.40M 2016-03-31 2016 Q1 10-Q 2016-05-09 0001162194-16-000206
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 541.12M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 193.62M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions investment 0 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -168.65M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 175.08M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 24.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual USD 30.60M 2024-01-06 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual USD 61.50M 2024-01-06 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap Cash Cash USD 17.68M 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 280.03M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 267.49M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 14.05M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 37.34M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 155.33M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 269.56M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 146.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrants 12.11 2011-07-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 26.51M 2026-06-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 600.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 413.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 394.67M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CommonStockValue Common Stock, Value, Issued USD 413,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 115.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 71,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 11.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 8.81M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 30.42M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 10.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 54.98M 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060385
us-gaap ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value USD 225.00M 2022-03-31 2022 Q1 10-Q 2022-05-09 0001162194-22-000055
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 46.47M 2024-03-18 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap CostMethodInvestments Cost Method Investments USD 1.30M 2012-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap CostMethodInvestmentsAggregateCarryingAmount Cost-method Investments, Aggregate Carrying Amount (Deprecated 2013-01-31) USD 1.30M 2012-12-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210608
us-gaap CostMethodInvestmentsFairValueDisclosure Cost Method Investments, Fair Value Disclosure USD 3.10M 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap CostMethodInvestmentsRealizedGainLoss Cost-method Investments, Realized Gain (Loss) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 27.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 21.38M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap CostOfRevenue Cost of Revenue USD 300,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 3.28M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap CostsAndExpenses Costs and Expenses USD 89.05M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -100,000 2020-01-01 2020 Q1 10-Q 2020-05-11 0001162194-20-000042
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 666,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 892,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 226,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DebtInstrumentBasisSpreadOnVariableRate Debt Instrument, Basis Spread on Variable Rate (Deprecated 2013-01-31) pure 0.01 2010-12-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210608
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.005 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-12 0001162194-14-000016
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 7.92M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 0.352 2022-03-25 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 65.58M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 600,000 2011-03-01 2011-03-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.20M 2011-02-01 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 497,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery Debt Securities, Available-for-sale, Allowance for Credit Loss, Sell before Recovery USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions investment 0 2020-12-31 2020 FY 10-K 2021-02-25 0001162194-21-000013
us-gaap DebtSecuritiesGainLoss Debt Securities, Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD -10.65M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001162194-22-000055
us-gaap DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Decrease in Unrecognized Tax Benefits is Reasonably Possible USD 800,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001162194-21-000087
us-gaap DeferredCompensationArrangementWithIndividualRecordedLiability Deferred Compensation Arrangement with Individual, Recorded Liability USD 3.30M 2026-03-31 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -33.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -407,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 273,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -38.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 13.95M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 823,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 10.76M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 4.79M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -4.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.00M 2014-12-31 2014 FY 10-K 2015-02-26 0001162194-15-000040
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 341.18M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 18.19M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 37.82M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 51.76M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 266.46M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 22.51M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.51M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 12.65M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 289.41M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 943,000 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 14.07M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 7.19M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2019-01-01 2019-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap Depreciation Depreciation USD 3.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 3.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 12.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 12.91M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal USD 39.20M 2026-01-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent USD 6.78M 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD -29.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.25 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001628280-21-009552
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.392 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.082 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.023 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.008 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -27,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -218,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.90M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.70M 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD 632,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInOtherIncome Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 906,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 274,000 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 121.09M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 11.01M 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 3.59M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 2.69M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 3.59M 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 3.59M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 3.59M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 3.59M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 149.15M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 28.06M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap GainLossOnSaleOfProject Gain (Loss) on Sale of Project USD 202.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -12,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001162194-16-000248
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001162194-15-000154
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -9,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap Goodwill Goodwill USD 111.72M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 5.11M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2022-08-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 86,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 300,000 2024-11-21 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 336,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap GrossProfit Gross Profit USD 32.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -51.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -68.53M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -51.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -28.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -38.15M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001162194-21-000072
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 164.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeTaxesPaid Income Taxes Paid USD 245,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 128,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -27.10M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -20.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 500,000 2015-12-18 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -871,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -1.30M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001162194-21-000072
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -4.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 841,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001162194-15-000040
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -5.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -2.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -5.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -30.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 3.02M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 368,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -6.66M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -3.84M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -322,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 829,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 11.69M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 75.16M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 52.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 28.06M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap InterestExpense Interest Expense USD 4.57M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap InterestExpenseOperating InterestExpenseOperating USD 26,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 44,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-26 0001193125-12-130255
us-gaap InterestIncomeOperating Interest Income, Operating USD 13.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 5.53M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 8.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 9.93M 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap InventoryGross Inventory, Gross USD 17.62M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryLIFOReservePeriodCharge Inventory, LIFO Reserve, Period Charge USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryNet Inventory, Net USD 17.62M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 18.28M 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 8.81M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 11.20M 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 700,000 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-057213
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 428,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 345,000 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 64.84M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 5.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap LeaseCost Lease, Cost USD 7.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LegalFees Legal Fees USD 400,000 2020-03-01 2020-03-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 39.39M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.43M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 8.42M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.22M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 8.24M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 8.02M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 8.07M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.42M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 8.86M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 6.35M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 527,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 1.53M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 1.48M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 1.43M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap Liabilities Liabilities USD 79.58M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 635.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.02M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap LineOfCredit Long-term Line of Credit USD 8.41M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 1.90M 2012-09-30 2012 Q3 10-Q 2012-11-09 0001193125-12-463140
us-gaap LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount USD 112,500 2018-08-01 2018-08-31 2021 Q2 10-Q 2021-08-06 0001162194-21-000072
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.055 2012-09-30 2012 Q3 10-Q 2012-11-09 0001193125-12-463140
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.038 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001162194-15-000040
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 10.00M 2014-12-31 2014 FY 10-K 2015-02-26 0001162194-15-000040
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 7.50M 2026-07-01 2026-07-31 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LitigationSettlementLoss LitigationSettlementLoss USD 600,000 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-04 0001193125-25-264695
us-gaap LongTermDebt Long-term Debt USD 299,000 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 10.60M 2011-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 5.00M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 2.92M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap LongTermInvestments Long-term Investments USD 98.24M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 2.30M 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-057213
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2016-09-30 2016 Q3 10-Q 2016-11-09 0001162194-16-000248
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap LossContingencyRangeOfPossibleLossMaximum Loss Contingency, Range of Possible Loss, Maximum (Deprecated 2016-01-31) USD 1.00M 2013-06-30 2013 Q2 10-Q 2013-08-07 0001193125-13-324552
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 77.72M 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -776,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 210.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -63.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 113.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -74.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -18.03M 2020-10-01 2020-12-31 2020 FY 10-K 2021-02-25 0001162194-21-000013
us-gaap NoncurrentAssets Long-Lived Assets USD 46.01M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap NumberOfReportingUnits Number of Reporting Units Unit 1 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064606
us-gaap OperatingExpenses Operating Expenses USD 90.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -57.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 30.53M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.69M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 20.84M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 23.08M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 3.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 10.26M 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 4.18M 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 552,000 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 827,000 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.25M 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.21M 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.24M 2018-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 1.71M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 532,000 2017-06-30 2017 Q2 10-Q 2017-08-08 0001162194-17-000091
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 0 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 181,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 523,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 741,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year USD 264,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 0 2017-09-30 2017 Q3 10-Q 2017-11-07 0001162194-17-000159
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.02M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001162194-18-000104
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 5.20M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.112 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 10,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-26 0001193125-12-130255
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 3.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 329,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001162194-20-000107
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 186,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 1.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 8.73M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.12M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 176,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 2.23M 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-057213
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -6.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 258,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 12.55M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 1.80M 2024-05-01 2024-05-31 2025 Q3 10-Q 2025-11-04 0001193125-25-264695
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap PaymentsForRestructuring Payments for Restructuring USD 10.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001162194-21-000072
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028287
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 974,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 60.54M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311107
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 137.30M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 169.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 839,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 5.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 914,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 139.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PreferredStockConversionsInducements Preferred Stock Conversions, Inducements USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 294.118 2022-03-31 2022 Q1 10-Q 2022-05-09 0001162194-22-000055
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264695
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PrepaidRoyalties Prepaid Royalties USD 1.10M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 25.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 410.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 225.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 120,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 827,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments Proceeds from Maturities, Prepayments and Calls of Other Investments USD 107.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 13.49M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311107
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 23.64M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001162194-20-000042
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProceedsFromSaleOfOtherInvestments Proceeds from Sale of Other Investments USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 536,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap ProductWarrantyAccrualAdditionsFromBusinessAcquisition Standard and Extended Product Warranty Accrual, Additions from Business Acquisition USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 875,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap ProductWarrantyAccrualPreexistingIncreaseDecrease Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties USD 241,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap ProductWarrantyAccrualWarrantiesIssued Standard and Extended Product Warranty Accrual, Increase for Warranties Issued USD 1.39M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001162194-21-000013
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 65.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 13.24M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 23,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001162194-16-000182
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 16.20M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 12.98M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RepaymentsOfDebt Repayments of Debt USD 2.10M 2012-09-01 2012-09-30 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 6.84M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 10.00M 2024-03-04 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RestrictedCash Restricted Cash USD 2.08M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001162194-19-000088
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 795,000 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 100,000 2014-09-30 2014 Q3 10-Q 2014-11-06 0001162194-14-000106
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 16,000 2022-06-30 2022 Q2 10-Q 2022-08-09 0001162194-22-000091
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 2.00M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap RestructuringCharges Restructuring Charges USD 7.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RestructuringReserve Restructuring Reserve USD 479,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 479,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.15B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 60.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 46,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-12 0001193125-13-103352
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 1.00M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 16.68M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap Revenues Revenues USD 51.68M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap SalesRevenueGoodsGross Sales Revenue, Goods, Gross (Deprecated 2018-01-31) USD 84.40M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 42.25M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 9.42M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001162194-18-000089
us-gaap SecuredDebt Secured Debt USD 9.39M 2022-09-30 2022 Q3 10-Q 2022-11-09 0001162194-22-000098
us-gaap SecuredDebtCurrent Secured Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 51.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 375,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 530,000 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 14.67 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001162194-19-000033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.961 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.16M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 10,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 5.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 6.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.23M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001445305-13-002845
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.9 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 476,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 33.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.68 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 943,000 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.37M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.13 2017-09-20 2018 Q3 10-Q 2018-11-06 0001162194-18-000104
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 24.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 300,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001162194-21-000013
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.85 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001162194-23-000013
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.16 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.71 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.17 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 11.35 2013-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 2.44M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 3.56M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost USD 300,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001162194-20-000016
us-gaap SharePrice Share Price USD/shares 1.28 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ShortTermInvestments Short-term Investments USD 40.87M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001162194-23-000024
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 11.30M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001445305-13-002845
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 555.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 11.48M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.21M 2012-07-22 2012-08-21 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 450.10M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 311.25M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 1.51M 2008-12-28 2009-12-31 2011 FY 10-K 2012-03-26 0001193125-12-130255
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 119,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 20.23M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-08 0001162194-22-000021
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -598,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 78,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001162194-15-000154
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 15.45M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122473
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 40.49M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 20.00M 2022-11-23 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 14.60M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028287
us-gaap SubleaseIncome Sublease Income USD 4.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap TechnologyServicesRevenue Technology Services Revenue (Deprecated 2018-01-31) USD 17.35M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap TemporaryEquityValueExcludingAdditionalPaidInCapital Temporary Equity, Par Value USD 0 2011-12-31 2011 FY 10-K 2012-03-26 0001193125-12-130255
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 1.98 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 18.58M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 46.47M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 2.10M 2021-06-30 2021 Q2 10-Q 2021-08-06 0001162194-21-000072
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 2.70M 2016-12-31 2016 FY 10-K 2017-03-03 0001628280-17-002137
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -2.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 10.20M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 138,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 357,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 561,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 372,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap USGovernmentAgenciesSecuritiesAtCarryingValue US Government Agencies Securities, at Carrying Value USD 0 2018-12-31 2018 FY 10-K 2019-03-18 0001162194-19-000020
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -15.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 119.23M 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 830,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap ValuationAllowancesAndReservesChargedToOtherAccounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account USD -27.89M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001162194-18-000032
us-gaap VariableLeaseCost Variable Lease, Cost USD 4.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108326
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 1.20M 2011-01-31 2013 FY 10-K 2014-03-12 0001162194-14-000010
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 64.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036608
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 390.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 74.71M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001628280-21-009552
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 390.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445534
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 7.34M 2023-12-31 2023 FY 10-K 2024-03-01 0000950170-24-023845

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →